Filing Flows

Filing Flows › ICU Medical (ICUI) › Next earnings date

ICU Medical (ICUI) earnings: beat the estimate

ICU Medical (ICUI) reported on Nov 5, 2026 and beat the EPS estimate: $2.44 against $2.15 (+13.6%). Revenue was $560M for Q3 2026, +4% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+13.6% vs estimate
Beat rate100%

The last report

ICU Medical reported revenue of $560M for the third quarter 2026 (+4% Y/Y), net earnings $26.8M: Infusion Consumables $298M, Infusion Systems $193M, Vital Care $69.5M. How it makes money → · Every quarter →

ICU Medical: EPS against the estimate, last 5 reportsICU Medical: EPS against the estimate, last 5 reportsEstimateReported$1.43$2.03Nov 25$1.69$1.91Feb 26$1.75$1.97May 26$1.91$2.37Aug 26$2.15$2.44Nov 26
Latest (Nov 26): Estimate $2.15, Reported $2.44.
ICUI: the stock's move on each reportICUI: the stock's move on each reportAug 6, 2026+10.9%May 7, 2026+5.7%Feb 19, 2026+3.6%Nov 6, 2025+10.0%

ICU Medical's latest quarter

ICU Medical, Q3 2026: revenue $560M (+4% year over year), operating margin 9.3%, net earnings $26.8M, operating cash flow $99.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did ICU Medical beat earnings?

ICU Medical (ICUI) reported on Nov 5, 2026 and beat the EPS estimate: $2.44 against $2.15 (+13.6%).

When does ICUI report earnings?

The next date is not set yet.

Does ICU Medical usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.